Lv1
76 积分 2025-07-26 加入
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
8天前
已完结
TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study
8天前
已完结
Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study
9天前
已完结
Fibrosis-driven hepatocarcinogenesis, metastasis and immune evasion: Mechanisms and therapeutic targets
1个月前
已完结
Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors
1个月前
已完结
Combination therapy strategies targeting glypican-3 in hepatocellular carcinoma: a comprehensive review
2个月前
已完结
1074 Reversal of resistance to PD-1 checkpoint blockade in hepatocellular carcinoma by NY-303, a GPC3 NK cell engager, inhibiting Wnt-GPC3-beta catenin signaling
2个月前
已完结
Development of a model combining CEUS LI-RADS and clinical features for predicting glypican-3 expression in hepatocellular carcinoma
2个月前
已完结
The role and mechanism of HIF-1α-mediated glypican-3 secretion in hypoxia-induced tumor progression in hepatocellular carcinoma
2个月前
已完结
Hepatic glypican-3 and alpha-smooth muscle actin overexpressions reflect severity of liver fibrosis and predict outcome after successful portoenterostomy in biliary atresia
3个月前
已完结
皖公网安备34019202002308
